CGEM
NASDAQ · Biotechnology
Cullinan Therapeutics Inc
$14.55
-0.17 (-1.15%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
+47.4% upside
Low Target
$16.94
Average Target
$21.45
High Target
$32.37
Current Price
$14.55
Current
$14.55
$14.55
Target
$21.45
$21.45
$16.94
$21.45 avg
$32.37
Scenario Analysis
Bear Case
$16.94
16.4%
Low target
Base Case
$21.45
+47.4%
Avg target
Bull Case
$32.37
+122.5%
High target
Risk/Reward
7.5x
Highly favorable
Price in Context
52-Week High
$16.74
-13.1% from high
52-Week Low
$5.68
+156.2% from low
Target vs 52W High
$21.45
+28.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +27.8% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 28 | 96% | $143.40 | +41.5% |